Tumor cells frequently overexpress the cystine/glutamate antiporter SLC7A11 to facilitate excessive cystine uptake for glutathione (GSH) biosynthesis—an essential antioxidant defense and contributor to chemoresistance [[26], [27], [28]]. The gene discussed is SLC7A11; the disease is neoplasm.